biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by frohlir944on Dec 28, 2018 11:02pm

132 Views

Post# 29167249

RE:RE:RE:RE:RE:RE:RE:DOW Largest Up Day Ever!! Over a 1000 Points!

You are truly annoying and a dolt. Go re-read; I’ve added 100 times, I have never sold a single share, but I have been adding for 7 years. For the love of all that is holy and good in this world; just stop TALKING. You are the most negative human I have ever met. Go do something positive anywhere in your life. I’m sure you need to.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property